Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Price:
0.61
USD
1.67%
Market Closed
Market Cap:
$24.9m
Balance Sheet
Balance Sheet Decomposition
Barinthus Biotherapeutics PLC
Barinthus Biotherapeutics PLC
Balance Sheet Decomposition is not available for
Barinthus Biotherapeutics PLC
Barinthus Biotherapeutics PLC
Balance Sheet
Barinthus Biotherapeutics PLC
Barinthus Biotherapeutics PLC
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
11
|
43
|
214
|
194
|
142
|
111
|
|
| Cash Equivalents |
11
|
43
|
214
|
194
|
142
|
111
|
|
| Total Receivables |
4
|
3
|
7
|
10
|
8
|
7
|
|
| Accounts Receivables |
1
|
1
|
0
|
6
|
0
|
0
|
|
| Other Receivables |
3
|
3
|
7
|
5
|
8
|
0
|
|
| Other Current Assets |
1
|
1
|
6
|
8
|
7
|
8
|
|
| Total Current Assets |
16
|
48
|
227
|
213
|
157
|
126
|
|
| PP&E Net |
3
|
3
|
9
|
16
|
19
|
12
|
|
| PP&E Gross |
3
|
3
|
9
|
16
|
19
|
12
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
4
|
9
|
|
| Intangible Assets |
0
|
0
|
31
|
28
|
25
|
22
|
|
| Goodwill |
0
|
0
|
13
|
12
|
12
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
13
|
12
|
12
|
0
|
|
| Total Assets |
19
N/A
|
51
+166%
|
281
+454%
|
270
-4%
|
215
-21%
|
160
-25%
|
|
| Liabilities | |||||||
| Accounts Payable |
4
|
5
|
2
|
4
|
2
|
2
|
|
| Accrued Liabilities |
1
|
3
|
8
|
8
|
11
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Current Liabilities |
6
|
8
|
11
|
12
|
13
|
16
|
|
| Long-Term Debt |
2
|
46
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
8
|
4
|
1
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
9
|
11
|
14
|
14
|
|
| Total Liabilities |
8
N/A
|
54
+602%
|
29
-47%
|
27
-4%
|
28
+2%
|
30
+9%
|
|
| Equity | |||||||
| Common Stock |
34
|
34
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
38
|
56
|
109
|
103
|
177
|
238
|
|
| Additional Paid In Capital |
16
|
20
|
369
|
380
|
387
|
393
|
|
| Other Equity |
0
|
1
|
8
|
33
|
23
|
26
|
|
| Total Equity |
11
N/A
|
4
N/A
|
252
N/A
|
243
-4%
|
187
-23%
|
130
-30%
|
|
| Total Liabilities & Equity |
19
N/A
|
51
+166%
|
281
+454%
|
270
-4%
|
215
-21%
|
160
-25%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
34
|
34
|
37
|
38
|
39
|
40
|
|
Switch to:
Switch to:
See Also
Discover More
